As of November 2024, Transgene has a market cap of $116.35M. This makes Transgene the world's 20411th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $131.15M | -14.60% |
2023 | $153.57M | -17.37% |
2022 | $185.85M | -34.72% |
2021 | $284.72M | 54.13% |
2020 | $184.73M | 6.32% |
2019 | $173.74M | -41.77% |
2018 | $298.36M | -3.53% |
2017 | $309.29M | 5.60% |
2016 | $292.90M | 4.28% |
2015 | $280.88M | -63.29% |
2014 | $765.03M | -20.27% |
2013 | $959.57M | 9.89% |
2012 | $873.23M | 3.77% |
2011 | $841.54M | -45.00% |
2010 | $1.53B | -32.64% |
2009 | $2.27B | 76.03% |
2008 | $1.29B | -18.84% |
2007 | $1.59B | 16.67% |
2006 | $1.36B | 80.00% |
2005 | $757.14M | 4.95% |
2004 | $721.44M | 4.22% |
2003 | $692.24M | 27.49% |
2002 | $542.98M | -29.30% |
2001 | $767.95M | -70.42% |
2000 | $2.60B | - |